CEO of LOBE Sciences Phil Young joined us to talk about how their company LOBE Sciences is planning on releasing a number of announcements over the next 30-60 days that include research being conducted in Australia involving new chemical entities associated with psilocin. He compares the difference between psilocybin and psilocin and the cost benefits psilocin provides

He also touches on the fact that the reason research is being done in Australia is because of the government grants psychedelics companies receive, including 43.1 cents on every dollar you spend on research in the country.

Also important to point out is that the share float for this company is a little over 38m shares, which means a tight share float. The last time LOBE Sciences released a couple of news releases was back in September when the share price moved from .03 to .28.